Key Insights

Highlights

Success Rate

78% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

14.3%

2 terminated out of 14 trials

Success Rate

77.8%

-8.7% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed with results

Key Signals

4 with results78% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (7)
P 1 (1)
P 2 (2)

Trial Status

Completed7
Terminated2
Unknown2
Not Yet Recruiting1
Active Not Recruiting1
Recruiting1

Trial Success Rate

77.8%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (14)

Research Network

Activity Timeline